Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CANCER TREATMENT AGENT INCLUDING MALT1 INHIBITING DRUG AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2023/149450
Kind Code:
A1
Abstract:
The combination of a cytotoxic anticancer agent and/or a molecularly targeted drug, and a MALT1 inhibiting agent that is a compound represented by formula (I) indicated in the specification, or a salt thereof, or a co-crystal, a hydrate, or a solvate thereof, demonstrates a strong antitumor effect, and thus is useful in treating blood cancer.

Inventors:
KOZAKI RYOHEI (JP)
FUJIKAWA RYU (JP)
ONO KAZUYA (JP)
MORISHITA DAISUKE (JP)
SATOH YOSHIHIKO (JP)
MIZUTANI AKIO (JP)
Application Number:
PCT/JP2023/003154
Publication Date:
August 10, 2023
Filing Date:
February 01, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ONO PHARMACEUTICAL CO (JP)
CHORDIA THERAPEUTICS INC (JP)
International Classes:
A61K31/444; A61K31/5025; A61K45/00; A61P35/00; A61P35/02; A61P43/00
Domestic Patent References:
WO2020111087A12020-06-04
WO2021000855A12021-01-07
WO2021241611A12021-12-02
Other References:
FENG SONG, ZHANG HAISHEN, TANG ZHIYONG, PENG XINGAO, YANG MIN, WEI XUDONG, ZHONG WENGE: "Direct Construction of Chiral Ether via Highly Efficient Heck Reaction and N-Directed Asymmetric Hydrogenation for Large-Scale Synthesis of MALT1 Inhibitor RGT-068A", ORGANIC PROCESS RESEARCH & DEVELOPMENT, AMERICAN CHEMICAL SOCIETY, US, vol. 26, no. 11, 18 November 2022 (2022-11-18), US , pages 3089 - 3095, XP093083206, ISSN: 1083-6160, DOI: 10.1021/acs.oprd.2c00229
Attorney, Agent or Firm:
KAMADA, Mitsunori et al. (JP)
Download PDF:



 
Previous Patent: LASER PROCESSING METHOD

Next Patent: LASER PROCESSING METHOD